文献速递心力衰竭与心肌病血脂与心血管预防

射血分数保留型心衰患者风险预测:LIFE-Preserved模型

Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model.
PubMed 文献 · Eur Heart J · 2026-01-01

该模型可识别高危HFpEF患者,辅助临床决策。

要点

  • LIFE-Preserved模型可预测HFpEF患者短期和终生心衰住院或心血管死亡风险。
  • 模型性能在男女间相似,已提供交互式计算器。

核心结论

  • LIFE-Preserved模型能预测HFpEF患者短期和终生心衰住院或心血管死亡风险,可用于识别高危患者并指导临床管理。

主要发现

  • 外部验证中9930例(35%)发生首次心衰住院或心血管死亡。
  • 模型性能在男性和女性中相似。

临床怎么用

  • LIFE-Preserved模型可用于HFpEF患者风险分层,识别高危个体以指导预防性治疗和共享决策。
  • 模型已提供交互式计算器,便于临床使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Heart failure (HF) with preserved ejection fraction (HFpEF) constitutes a heterogeneous disease with varying prognosis. Given the rising incidence of HFpEF, accurate risk prediction for these patients is needed to identify high-risk individuals, who may benefit the most from preventive treatments. The LIFE-Preserved model was developed and validated for the prediction of individual short-term and lifetime risk for HF hospitalization or cardiovascular (CV) death in patients with HFpEF. METHODS: LIFE-Preserved was derived in 20 332 patients aged 40-90 years with a left ventricular ejection fraction ≥ 50% from the Swedish HF Registry. Cause- and sex-specific Cox models were derived to predict the risk of HF hospitalization or CV death using 14 routinely available predictors. Use of age as the timescale allowed for predictions beyond the maximum follow-up duration in the derivation data, adjusted for competing risks. External validation was performed in two trials (EMPEROR-Preserved and TOPCAT-Americas) and three registries (NHS England Secure Data Environment, Veterans Affairs, and HF-Particles). Model performance was assessed by discrimination and calibration. RESULTS: During a median follow-up of 1.8 years (interquartile range .6-4.2, maximum 19 years), 9341 first HF hospitalizations or CV deaths (46%) were observed in Swedish HF Registry. External validation included data from 28 062 patients with HFpEF [9930 (35%) first HF hospitalizations or CV deaths]. Pooled C-statistics were .714 (95% confidence interval .652-.775) in trials and .658 (95% confidence interval .599-.717 in registries, with adequate calibration in all external validation sources. Performance was similar in men and women. An interactive calculator of the LIFE-Preserved model has been made available here. CONCLUSIONS: The LIFE-Preserved model enables prediction of short-term and lifetime risk of HF hospitalization or CV death in patients with HFpEF. The model could serve as a tool to identify high-risk HFpEF patients, guiding clinical management and shared decision-making.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Reitsma TH, Savarese G, Kuźma Ł, et al. Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model. Eur Heart J. 2026. PMID: 41810940. doi:10.1093/eurheartj/ehag182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。